Evolution of a gastric carcinoma cell-specific DNA aptamer by live cell-SELEX

Oncology Reports

Volumn 32, Issue 5, 2014, Pages 2054-2060

  Cao, Hong Yong ^a,b   Yuan, Ai Hua ^a   Shi, Xue Song ^a   Chen, Wei ^a   Miao, Yi ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

DNA aptamer; Fluorescence imaging; Gastric cancer; Live cell SELEX; Molecular probe

Indexed keywords

APTAMER; CELL DNA; SINGLE STRANDED DNA;

AGS CELL LINE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BIOLOGICAL MONITORING; CARCINOMA CELL; CELL ADHESION; CELL CLONING; CELL LINE; CELL SELECTION; CELL SPECIFICITY; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE IMAGING; GASTRIC CANCER CELL LINE; GEL ELECTROPHORESIS; GES 1 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; STOMACH CARCINOMA; STOMACH EPITHELIUM; TARGET CELL; DIAGNOSTIC USE; EARLY DIAGNOSIS; ENZYME SPECIFICITY; GENETICS; HEPG2 CELL LINE; MOLECULARLY TARGETED THERAPY; PROCEDURES; STOMACH NEOPLASMS; SYNTHESIS; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; CELL LINE, TUMOR; EARLY DETECTION OF CANCER; HEP G2 CELLS; HUMANS; MOLECULAR TARGETED THERAPY; SELEX APTAMER TECHNIQUE; STOMACH NEOPLASMS; SUBSTRATE SPECIFICITY;

EID: 84907285751     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3411     Document Type: Article

References (23)

1. Pietrantonio F, De Braud F, Da Prat V, et al: A review on biomarkers for prediction of treatment outcome in gastric cancer. Anticancer Res 33: 1257-1266, 2013.
2. Takahashi T, Saikawa Y and Kitagawa Y: Gastric cancer: current status of diagnosis and treatment. Cancers 5: 48-63, 2013.
3. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
4. Yang S and Chung HC: Novel biomarker candidates for gastric cancer. Oncol Rep 19: 675-680, 2008.
5. Lassalle HP, Marchal S, Guillemin F, et al: Aptamers as remarkable diagnostic and therapeutic agents in cancer treatment. Curr Drug Metab 13: 1130-1144, 2012.
6. Radom F, Jurek PM, Mazurek MP, et al: Aptamers: molecules of great potential. Biotechnol Adv 31: 1260-1274, 2013.
7. Hermann T and Patel DJ: Adaptive recognition by nucleic acid aptamers. Science 287: 820-825, 2000.
8. Tuerk C and Gold L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505-510, 1990.
9. Stoltenburg R, Reinemann C and Strehlitz B: SELEX-A (r) evolutionary method to generate high-Affinity nucleic acid ligands. Biomol Eng 24: 381-403, 2007.
10. Sefah K, Shangguan D, Xiong X, et al: Development of DNA aptamers using Cell-SELEX. Nat Protoc 5: 1169-1185, 2010.
11. Cerchia L and de Franciscis V: Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol 28: 517-525, 2010.
12. Shangguan D, Li Y, Tang Z, et al: Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci USA 103: 11838-11843, 2006.
13. Sefah K, Tang ZW, Shangguan DH, et al: Molecular recognition of acute myeloid leukemia using aptamers. Leukemia 23: 235-244, 2009.
14. Zhang K, Sefah K, Tang L, et al: A novel aptamer developed for breast cancer cell internalization. Chem Med Chem 7: 79-84, 2012.
15. Kunii T, Ogura S, Mie M and Kobatake E: Selection of DNA aptamers recognizing small cell lung cancer using living cell-SELEX. Analyst 136: 1310-1312, 2011.
16. Sefah K, Meng L, Lopez-Colon D, et al: DNA aptamers as molecular probes for colorectal cancer study. PLoS One 5: e14269, 2010.
17. Zhu G, Ye M, Donovan MJ, et al: Nucleic acid aptamers: an emerging frontier in cancer therapy. Chem Commun 48: 10472-10480, 2012.
18. Zhang Y, Chen Y, Han D, et al: Aptamers selected by cell-SELEX for application in cancer studies. Bioanalysis 2: 907-918, 2010.
19. Sefah K, Bae KM, Phillips JA, et al: Cell-based selection provides novel molecular probes for cancer stem cells. Int J Cancer 132: 2578-2588, 2013.
20. Zueva E, Rubio LI, Ducongé F and Tavitian B: Metastasisfocused cell-based SELEX generates aptamers inhibiting cell migration and invasion. Int J Cancer 128: 797-804, 2011.
21. Berezovski MV, Lechmann M, Musheev MU, et al: Aptamerfacilitated biomarker discovery (AptaBiD). J Am Chem Soc 130: 9137-9143, 2008.
22. Fang X and Tan W: Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res 43: 48-57, 2009.
23. Pavlou MP, Diamandis EP and Blasutig IM: The long journey of cancer biomarkers from the bench to the clinic. Clin Chem 59: 147-157, 2013.